Offer - Urjas Oil for just ₹ 1 X
Migrof 5 Capsule SR, a prescription drug, is manufactured in various forms such as Capsule. It is primarily used for the treatment of Migraine.
The right dosage of Migrof 5 Capsule SR depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Migrof 5 Capsule SR include Weakness. Besides the aforementioned side effects, there are other adverse effects of Migrof 5 Capsule SR as well, which are listed below. Normally, these side effects of Migrof 5 Capsule SR are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Migrof 5 Capsule SR's effect is Moderate during pregnancy and Mild for lactating mothers. It is important to know if Migrof 5 Capsule SR has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Migrof 5 Capsule SR related warnings section.
Migrof 5 Capsule SR is contraindicated in people with pre-existing medical conditions like Liver Disease, Heart Disease, Wolff Parkinson White Syndrome as it can result in adverse effects. Other conditions have been mentioned below in the Migrof 5 Capsule SR contraindications section.
Additionally, Migrof 5 Capsule SR may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Migrof 5 Capsule SR is considered not safe while driving, and is not addictive.
Migrof 5 Capsule SR is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Migrof 5 Capsule SR safe for pregnant women?
Migrof may have some side effects during pregnancy. Pregnant women should discontinue the use of Migrof, and talk to their doctor, if they notice any discomfort.
Is the use of Migrof 5 Capsule SR safe during breastfeeding?
Migrof may have very limited harmful effects for breastfeeding women.
What is the effect of Migrof 5 Capsule SR on the Kidneys?
Very few cases of side effects of Migrof on kidney have been reported.
What is the effect of Migrof 5 Capsule SR on the Liver?
Migrof has very mild side effects on the liver.
What is the effect of Migrof 5 Capsule SR on the Heart?
Side effects of Migrof rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Migrof 5 Capsule SR unless your doctor advises you to do so -
Is this Migrof 5 Capsule SR habit forming or addictive?
Migrof 5 Capsule SR is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Migrof 5 Capsule SR as you may feel sleepy.
Is it safe?
Yes, Migrof 5 Capsule SR is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Migrof 5 Capsule SR in mental disorders is not effective.
Interaction between Food and Migrof 5 Capsule SR
Taking Migrof 5 Capsule SR with food does not harm your health.
Interaction between Alcohol and Migrof 5 Capsule SR
No research has been done on this till date. Therefore, it is not known what the effect of taking Migrof 5 Capsule SR with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Maxalt (rizatriptan benzoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 179
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1112-1113